Teachers Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History

Teachers Advisors’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-228	Closed	-$31K	–	3136
2017 Q1	$31K	Hold	228	–	–	﹤0.01%	3043
2016 Q4	$36K	Buy	228 +142	+165%	+$27.2K	﹤0.01%	3067
2016 Q3	$21K	Hold	86	–	–	﹤0.01%	3063
2016 Q2	$76K	Hold	86	–	–	﹤0.01%	3062
2016 Q1	$78K	Hold	86	–	–	﹤0.01%	2976
2015 Q4	$121K	Hold	86	–	–	﹤0.01%	2989
2015 Q3	$143K	Hold	86	–	–	﹤0.01%	2960
2015 Q2	$184K	Buy	86 +49	+132%	+$94.8K	﹤0.01%	2987
2015 Q1	$68K	Hold	37	–	–	﹤0.01%	3060
2014 Q4	$89K	Buy	+37	New	+$87.8K	﹤0.01%	3058

Other funds holding ELDN

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSC

Lyon Street Capital Sausalito, California $67M AUM

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Teachers Advisors's ELDN Position: Q2 2017 in Review

Teachers Advisors sold out of Eledon Pharmaceuticals (ELDN) in Q2 2017, closing a stake of 228 shares — an estimated $31K sold.

Teachers Advisors first reported a position in ELDN in Q4 2014 and held it in 10 quarters. The position peaked at $184K in Q2 2015. 19 funds tracked by Wall St. Rank hold ELDN as of Q2 2017.

Teachers Advisors reported no remaining Eledon Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Teachers Advisors sold 228 Eledon Pharmaceuticals shares in Q2 2017, an estimated $31K.
Teachers Advisors first reported a position in Eledon Pharmaceuticals in Q4 2014 and held it in 10 quarters.
Teachers Advisors's Eledon Pharmaceuticals position peaked at $184K in Q2 2015.
19 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.